About Conference

ConferenceSeries Ltd invites all the participants from all over the world to attend "23rd World Congress on Pediatric Oncology and Nursing" during July 27-28, 2023 in Vancouver, Canada which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Pediatric Oncology 2023 has an incidence of more than 175,000 per year, and a mortality rate of approximately 96,000 per year. In developed countries, childhood cancer has a mortality of approximately 20% of cases. In low resource settings, on the other hand, mortality is approximately 80% , or even 90% in the world's poorest countries. In many developed countries the incidence is slowly increasing, as rates of childhood cancer increased by 0.6% per year between 1975 to 2002 in the United States and by 1.1% per year between 1978 and 1997 in Europe. ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

CME Statement
In support of improving patient care, this activity has been planned and implemented by Conference Series, Ltd and Center for Education Development (CED). CED is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement
Center for Education Development designates the live format for this educational activity for AMA PRA Category 1 Credits™ and ANCC credit. Participants should only claim credit commensurate with the extent of their participation in the activity. Full accreditation information including disclosures, credit hours available and faculty information will be provided in the attendee handout onsite.

Why to attend?
To create opportunity for creative people and the companies they work with to develop their careers, to bring together people from a wide area to meet and share ideas. To become familiar with the Pediatric Oncology related tools available today, their cost, how they are used at other institutions and how they can be put to use in your research or project. Hear from self-taught experts in Pediatric Oncology as they share their successes and failures.

Target Audience:
• Pediatric Oncology and Pediatric Medicine Students, Scientists
• Pediatric Oncology and Pediatric Medicine Researchers
• Pediatric Oncology and Pediatric Medicine Faculty
• Medical Colleges
• Pediatric Oncology and Pediatric Medicine Associations and Societies
• Business Entrepreneurs
• Training Institutes
• Pharmaceutical Manufacturing Companies
• Software Developing Companies
• Data Management Companies
• Pediatric Oncology and Pediatric Medicine Physicians

Sessions/Tracks

Track 1: Pediatric Oncology

Pediatric oncology is a strength discipline in drug concerned with diagnosing and treating kids, as a rule up to the age of 18, with malignancy. It is thought to be one of the most challenging of specialties because, despite successful treatment of many children, there is a high death rate still connected with different sorts of malignancies. Sorts of Pediatric Oncology incorporate Pediatric Hematology Oncology, Pediatric Leukemia, Neuroblastoma in Children, Brain Tumor in Children, Clinical Trials, Advances in Pediatric Oncology Treatment, Oncology Nursing and Care, Advanced Pediatric Oncology Drugs, Pediatric Radiation Oncology, Pediatric Oncology Diagnostic, Radiotherapy Oncology, Pediatric Neuro-Oncology.

Track 2: Clinical Pediatrics

The aim of the study of pediatrics is to reduce infant and child rate of deaths, control the spread of infectious disease, promote healthy lifestyles for a long disease-free life and help ease the problems of children and adolescents. It can be acknowledged that this can be reached by learning the major and primary subject on General Pediatrics. General Pediatrics includes the basic treatments involved for the betterment of pediatric health. The most significant problems can be due to nutritional deficiencies to the overall health of infants and children because growth and development can be seriously hindered by shortages in essential vitamins or nutrients.

Track 3: Types of Pediatric Oncology

The most common cancer in children is Leukemia, which is cancers of the bone marrow and blood, are the most common childhood cancers. They account for about 30% of all cancers in children. Brain and central nervous system tumors are the second most common cancers in children, making up about 26% of childhood cancers. Neuroblastoma starts in early forms of nerve cells found in a developing embryo or fetus. About 6% of childhood cancers are neuroblastomas. Wilms tumor starts in one, or rarely, both kidneys. It is most often found in children about 3 to 4 years old. It can show up as a swelling or lump in the belly (abdomen). It accounts for about 5% of childhood cancers. Lymphoma start in certain cells of the immune system called lymphocytes. They most often grow in lymph nodes and other lymph tissues, like the tonsils or thymus. Rhabdomyosarcoma starts in cells that normally develop into skeletal muscles. It makes up about 3% of childhood cancers. Osteosarcoma is most common in teens, and usually develops in areas where the bone is growing quickly, such as near the ends of the long bones in the legs or arms. Ewing sarcoma is a less common type of bone cancer, which can also cause bone pain and swelling. It is most often found in young teens. Germ cell tumors make up about 3% of all childhood cancers. Ninety percent of germ cell tumors are gonadal which are found in the ovaries or testicles and are more common in children and adolescents. Pleuropulmonary blastoma (PPB) is a rare childhood cancer occurring in the chest, specifically in the lungs or in the coverings of the lungs called "pleura". Hepatoblastoma is the most common primary liver tumor in children, accounting for just over 1% of pediatric cancers.

Track 4: Pediatric Hematology Oncology

Pediatric hematology is the branch of pediatrics dealing with study, diagnosis, treatment and prevention different types of blood disorders including the study of bleeding and clotting disorders in children. The study of Tumor Cell Biology reviews applications concerned with signal transduction mechanisms in neoplastic cells, and regulation of tumor cell phenotype and behaviour, and tumor progression. It important to study causes, risk factors and the hypothesis in pediatrics with hematology disorders. A medical practitioner who specializes in this field of pediatric hematology is called pediatric hematologist. It is important that one should be familiar with the educational and preventive measures in order to prevent children being affected with blood disorders.

Track 5: Pediatric Leukemia

Leukemia is usually described either as "acute", which grows quickly, or "chronic", which grows slowly. One main type of acute leukemia is acute lymphocytic leukemia (ALL), which accounts for about 3 out of 4 cases of leukemia in children. ALL is a form of leukemia that affects the lymphocytes, a type of white blood cells which fights infection. Another type of acute leukemia is acute myelogenous leukemia (AML). AML is cancer of the blood in which too many myeloblasts, immature white blood cells, are produced in the bone marrow. Chronic leukemias are more common in adults than in children, and although they tend to grow more slowly than acute leukemias, they are harder to treat. These chronic leukemias are divided into two types: chronic myelogenous leukemia (CML) and chronic lymphocytic leukemia (CLL). CML is rare in children, but does occur and is treatable in children the same as in adults. CML patients have too many immature white blood cells being produced, and the cells crowd the other healthy blood cells. Juvenile myelomonocytic leukemia (JMML) is a form of leukemia that is neither chronic nor acute and occurs most often in children under the age of four. JMML begins from myeloid cells, but is not as fast-growing as AML or as slow as CML.

Track 6: Pediatric Radiology

Intensity-modulated radiation therapy (IMRT), a type of external beam radiation therapy, is the most commonly used approach for pediatric patients. This computer-guided technology can precisely target cancer cells, which reduces the radiation delivered to nearby normal tissue and minimizes side effects. X-rays, CT scanning, MRI scanning, ultrasound and other radiological techniques to localise and guide biopsy. Scintigraphy, Single Photon Emission Computed Tomography (SPECT), Positron emission tomography (PET) and other methods of nuclear medicine to identify areas suspicious for malignancy.

Track 7: Pediatric Neuro- Oncology

The management of children with brain and spinal cord tumors is extremely complex. Pediatric brain cancers can be stubborn, and typically do not respond to traditional chemotherapy and radiation. in part because the brain is somewhat protected from medications the blood-brain barrier, in part because surgery in the brain has to be quite refined to minimize injury to brain tissue, and in part because radiation treatment to the brain can cause injury to normal brain tissue.

Track 8: Genetics in Pediatric Oncology

Pediatric cancer sometimes generate genetically. The roots of pediatric cancer are hidden deep within a child’s DNA. Researchers are working on Pediatric Cancer Genome Project which is the world’s most ambitious effort to discover the origins of childhood cancer and seek new cures.

Track 9: Pediatric Oncology Diagnosis

The purpose of Diagnostic and Therapeutic Advances in Pediatric Oncology for the Cancer Treatment and Research Series is to provide an up-to-date summary of how recent advances in cancer research are being applied to the care of children with solid tumors. Pediatric diagnostic radiation uses medical imaging to diagnose and treat medical conditions in children.

Track 10: Pediatric Oncology Treatment

Certain disorders (such as ALL or AML) will require immediate admission and chemotherapy, while others will be followed up with regular physical examination and blood tests. Often, surgery is attempted to remove a tumor entirely. This is only feasible when there is some degree of certainty that the tumor can in fact be removed. Surgery is also used for the palliative treatment of some of cancers, e.g. to relieve biliary obstruction, or to relieve the problems associated with some cerebral tumors. The risks of surgery must be weighed against the benefits. A Bone marrow transplant is a medical procedure in which bone marrow that contains cancer is replaced by highly specialized cells, called hematopoietic stem cells, that develop into healthy bone marrow. Chemotherapy and radiotherapy are used as a first-line radical therapy in a number of malignancies. They are also used for adjuvant therapy, i.e. when the macroscopic tumor has already been completely removed surgically but there is a reasonable statistical risk that it will recur. Chemotherapy and radiotherapy are commonly used for palliation, where disease is clearly incurable. There is currently a rapid expansion in the use of monoclonal antibody treatments, notably for lymphoma (Rituximab), and breast cancer (Trastuzumab). Vaccine and other immunotherapies are the subject of intensive research.

Track 11: Pediatric Cancer Care

By optimizing our high-performance computing, we enable researchers to analyze and store massive amounts of genetic data more quickly than ever before. Through the cloud, medical professionals map tumor characterizations to the treatment database, which ultimately allows patients quicker access to better treatment. Researchers are now able to analyze a patient’s molecular data — a process that used to take 10 days — in six hours.

Track 12: Pediatric Comprehensive Cancer Care

Childhood cancer is a region of oncology that has seen both striking improvement and in addition generous proceeding with challenges. While survival rates for some pediatric growths display an account of achievement, for some sorts of pediatric malignancies, little advance has been made. Numerous growth medications are known to cause noteworthy intense reactions, as well as prompt various long term health hazards and decreased risks. Indeed, even in situations where the disease is viewed as reparable, the outcomes of treatment display considerable long term health and psychosocial concerns for kids, their families, their communities, and our health system.

Track 13: Pediatric Oncology Nursing

It can be frightening to hear that a child has cancer or a blood disorder. It is acknowledged that Neuroblastoma is the most common extracranial solid tumor of infancy. It is an embryonal malignancy of the sympathetic nervous system arising from neuroblasts (pluripotent sympathetic cells). Researchers are looking for genetic source of childhood brain tumors. Their main target is Germ cell tumors (GCTs) in children which are masses of tissue formed by the type of immature cells. Germ cell tumors may be malignant, which means cancerous, or they may be benign, which means noncancerous. The common blood disorders in children are leukemia and lymphoma. Leukemia is a disease of the white blood cells. The most common type of pediatric leukemia is acute lymphocytic leukemia. Other types of leukemia that occur less frequently in children are acute myeloid leukemia, and chronic myeloid leukemia. Lymphomas (Hodgkin and non-Hodgkin lymphoma) are the third most common cancer in children. Based on the characteristics and microscopic appearance of the cancer cell, the pediatric lymphomas are divided into Hodgkin Lymphoma and non-Hodgkin lymphoma. This Session Includes Pediatric Brain Tumor Models, Neurocutaneous Disorders, Neurofibromatosis, Primitive neuroectodermal tumor, Leukemia, Epigenetics in Pediatric Cancers, Pediatric Neurobiology and Proton Radiotherapy for Pediatric Brain Tumors.

Track 14: Pediatric Nursing

Pediatric nursing is the restorative care of neonates and children up to adolescent, more often than not in an in-understanding doctor's facility or day-center. The main part of pediatric nurses is to regulate specifically methodology and pharmaceuticals to youngsters as per endorsed nursing care designs. Nurses likewise evaluate the patient by watching fundamental signs, and creating relational abilities with child and families and with restorative groups. Being a help to youngsters and their families is one segment of direct nursing care. Familiarity with the worries of children and parent, being available physically on occasion of stress and implementing systems to enable children and families to adapt are all part of the work.

Track 15: Neonatal and Perinatal Nursing

Neonatal nursing is a subspecialty of nursing look after babies up to 28 days after birth. Neonatal nursing requires a high level of skills, devotion and passionate quality as the nurses tend to babies with a scope of issues, prematurity, birth defects, disease, cardiovascular abnormalities and surgical issues. Neonatal nurses are an indispensable piece of the neonatal care group and are required to know fundamental infant revival, have the capacity to control the infant's temperature and know how to start cardiopulmonary and pulse oximetry monitoring. Perinatal nursing is a nursing that works with patients who are planning to become pregnant, are right now pregnant, or have recently delivered. Perinatal Nurses help to give pre-birth care and testing, care of patients experiencing pregnancy complications, care during labour and delivery. Perinatal Nurses work with obstetricians, birthing specialists, and attendant professionals.

Track 16: Palliative Pediatric Nursing

Pediatric Palliative care is a multidisciplinary way to deal with specific therapeutic and nursing watch over child with life-timing diseases. It centers on giving alleviation from the side effects, physical stress and mental stress of a terminal diagnosis. The objective is to enhance personal satisfaction for both the individual and their family. .

Track 17: General Pediatrics Nursing

General Pediatric gives the nursing consideration to children of any age experiencing chronic and acute surgical and medicinal conditions. Pediatric Nurses are profiled in a few intense care departments, surgery wards and care units. Nurses give social insurance needs of every single normal issue and instruct the patients and their families to build up the personal satisfaction. According to recent surveys, number of child death is expanding each year because of absence of advanced healthcare equipment. Thus Medical Practitioners and nurses are in the forefront to reduce the death rates the world over.

Track 18: Nursing in Pediatric Intensive Care Unit

A pediatric intensive care unit is an area where the care of critically ill infants, children, and teenagers are done. A PICU is typically directed by one or more pediatric intensivists or PICU consultants and staffed by doctors especially by nurses who are trained and experienced in pediatric intensive care. The unit may also have physician assistants, nurse practitioners, social workers, child life specialists, and though this varies widely depending on geographic location.

Track 19: Pediatric Emergency Nursing

focused on the care of children with medical emergencies, that is, those who require prompt medical attention to avoid long-term disease or death. Pediatric emergency nurses may also work in urgent care centers, sports arenas, and on medical transport helicopters and ambulances.

Track 20: Clinical Trials

Clinical trials are used to determine the most effective and safest treatment for a disease. Each trial is aimed at improving survival rates or reducing side effects or late effects of treatment. It is important to understand that clinical trials are standard practice in cancer treatment for children, adolescents and young adults. While less than five percent of adults with cancer are enrolled in clinical trials, 60 percent of patients under age 29 diagnosed with cancer are enrolled in trials.

Market Analysis

“23rd World Congress on Pediatric Oncology and Nursing” will be held during July 27-28, 2023 in Vancouver, Canada with the theme “The research and treatment of cancers in children and young adults”. Pediatric Oncology Conference 2023 mainly covers the knowledge in the field of Oncology in children’s and neonates. Conference Series LLC LTD is inviting you to join us at Pediatrics Oncology 2023, where you will get to experience scholars from the whole world. All organizing members of the Pediatric Oncology Conference 2023 look forward to meeting you in Canada.

Pediatric oncology and nursing are specialized fields within the broader healthcare industry that focus on the diagnosis, treatment, and care of children with cancer. These fields have become increasingly important in recent years due to several factors, including a rising incidence of childhood cancer, advances in cancer treatment technologies, and a growing emphasis on patient-centered care.

According to a report by Grand View Research, the global pediatric oncology market size was valued at USD 4.4 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.1% from 2021 to 2028. The increasing prevalence of pediatric cancer, a rise in the number of government initiatives to promote research on pediatric cancer, and a growing number of specialized healthcare centers focusing on pediatric oncology are some of the key factors driving the growth of the market.

In terms of region, North America dominates the global pediatric oncology market due to the presence of advanced healthcare infrastructure, higher healthcare expenditure, and a larger number of clinical trials and research studies. Europe and the Asia Pacific are also expected to witness significant growth in the pediatric oncology market due to the rising prevalence of pediatric cancer and increasing government initiatives to promote research and development in this field.

Pediatric oncology nursing is also an important aspect of the healthcare industry, providing specialized care to children with cancer. According to the National Association of Pediatric Nurse Practitioners, there is a growing demand for pediatric oncology nurses, with the number of pediatric oncology nurse practitioners expected to increase by 26% by 2028. This is due to the increasing incidence of pediatric cancer, the development of new cancer treatments, and a growing emphasis on patient-centered care.

The pediatric oncology and nursing market is also witnessing a shift towards personalized medicine, where treatments are tailored to the specific needs of individual patients. This approach involves the use of genomic testing, molecular profiling, and other advanced technologies to identify specific genetic mutations that cause cancer and develop targeted therapies to treat them. This trend is expected to drive the growth of the pediatric oncology and nursing market in the coming years.

In conclusion, the pediatric oncology and nursing market is growing steadily due to several factors, including a rising incidence of pediatric cancer, advances in cancer treatment technologies, and a growing emphasis on patient-centered care. The market is expected to witness continued growth in the coming years due to the increasing demand for specialized healthcare services and a focus on personalized medicine.

Conference Highlights:

• Pediatric Oncology
• Clinical Pediatrics
• Types of Pediatric Oncology
• Pediatric Hematology Oncology
• Pediatric Leukemia
• Pediatric Radiology
• Pediatric Neuro- Oncology
• Genetics in Pediatric Oncology
• Pediatric Oncology Diagnosis
• Pediatric Oncology Treatment
• Pediatric Cancer Care
• Pediatric Comprehensive Cancer Care
• Pediatric Oncology Nursing
• Pediatric Nursing
• Neonatal and Perinatal Nursing
• Palliative Pediatric Nursing
• General Pediatrics Nursing
• Nursing Pediatric Intensive Care Unit
• Pediatric Emergency Nursing
• Clinical Trials

Importance and Scope:

Today, due to propels in treatment, more than 7 out of 10 youngsters treated for disease make due no less than 5 years, and the majority of these kids are cured. In any case, the medicines that assistance these kids survive their malignancy can likewise cause medical issues later on. Most treatment symptoms show up amid or soon after treatment and leave a short time later. Since more youngsters with the disease now get by into adulthood, their long-haul wellbeing and these late impacts have turned into a concentration of care and research. Cautious follow-up after tumor treatment enables specialists to discover and regard any late impacts as ahead of schedule as could reasonably be expected. The subsequent calendar relies upon numerous things, including the kind of tumor the youngster had, the medications utilized, the danger generally impacts from those medicines, and different factors, for example, the patient's age and to what extent it has been since treatment was finished.

Pediatric Oncology Conference 2023 is a stage to evaluate the progress in pediatric oncology-related tools and techniques for the campaign against cancer in children and to the spread of learning in pediatric oncology for the advantage of both the scholarly community and business. This occasion unites Pediatric oncologist, pediatric medicine specialist, child Specialists and all the prominent analysts and specialists in the field of Pediatric Oncology.

Market Value on Pediatric Oncology Research

Pediatric oncology patients are additionally expelled from being little adults than other pediatric patient populaces with more seasoned partners. While youngsters are influenced by distinctive types of growth than grown-ups, there likewise exists a noteworthy contrast amongst kids and grown-ups with respect to treatment and improvement of new oncology treatments. The conspicuous variety is the idea of survival. With grown-up malignancy patients, it is satisfactory to look to prompt, five-and 10-year survival rates, alongside personal satisfaction, for the best approximations of restorative achievement. Then again, a kid malignancy tolerant gets treatment to be cured. A run of the mill distinction amongst child and pediatric oncologists is in treatment conventions; pediatric conventions are substantially more energetic, regularly hitting patients as hard as conceivable to accomplish an effective, long-term cure.

Market Growth of Pediatric Oncology Research in the last and upcoming five years

An expected 2,000 kids die from cancer every year, and the general frequency of youth cancer has been gradually expanding since 1975. Regardless of critical advances against certain pediatric tumors, including intense lymphoblastic leukemia, there are still a few sorts of malignancy for which there are very few or no medicines are available. A commonsense reason: Childhood malignancies make up less than 1 percent of all tumors analyzed every year, as indicated by the American Cancer Society. That 1 percent isn't a lot of a business opportunity for drugmakers, who pile on an expected $1.4 billion in out-of-stash costs while offering a novel medication for sale to the public. They could never recover that treating the 700 kids determined to have neuroblastoma every year. Most pediatric clinical trials are worked by the National Cancer Institute's (NCI) Children's Oncology Group (COG), which runs around 40 to 50 remedial trials the nation over at any one time, as per Peter Adamson, director of the association and a pediatric oncologist at the Children's Hospital of Philadelphia. However even with government financing, pediatric malignancy explore gets just a small amount of the cash that grown-up growth inquire about gets, and it's diminishing. In 2013, the NCI contributed $185.1 million from a $4.79 billion spending plan for pediatric growth explore, the most minimal sum since 2009.

Fund Allotment for Pediatric Oncology Research

Adolescence disease is disregarded significantly by the National Cancer Institute. The NCI allotted a hopeless 4% of its assets to all adolescence growths which are comprised of various diverse sorts including Leukemia, Neuroblastoma, Rhabdomyosarcoma, Wilms Tumor and numerous others which are exceptionally extraordinary in finding, structure, and research. In the course of recent years, the NCI has lessened it's subsidizing towards pediatric disease inquire about from $240 million out of 2009 to $197 million of every 2011. In the meantime, it has expanded its financing every year for Breast Cancer look into, a solitary kind of disease, to $631 Million. Furthermore, the American Cancer Society, the second greatest supporter of Breast Cancer look into and the biggest generator of gifts additionally gives a horrid 1% to adolescence tumor.

Why to Attend?

This international oncology conference provides a great scope for the oncologist and the companies they work with, to bring together cancer-related people from a wide area to meet and share their ideas. People will become familiar with the Pediatric oncology-related machines available today, their cost, how they are handled at other institutions and how they are using in your research or project. Self-taught oncologists will share their successes and failures in childhood cancer.

Abstract Submission Criteria & Eligibility

PRESENTATION REQUIREMENTS:

• Presenting authors are responsible for registration, travel, and hotel costs. Note: Those with accepted abstracts will receive an acceptance mail allowing them to register for the conference.

• Abstracts will be compiled and conference books are made available to participants at the conference.

• Any presenter who is unable to attend should arrange for another qualified individual to present the paper/poster in question. If such a change is necessary, please notify our conference team

SUBMISSION OPTIONS:

• Oral paper presentations will have 30-minute time slots and be clustered by theme into sessions. The keynote session will have for 45-minute time slot, workshop/ special session will have 60-minute time slot and symposium will have 60-minute time slot followed by 5-minute Q&A session.

• Graduate & Masters students are eligible to submit their abstracts under poster and e-poster presentation category.

• Ph.D. students are eligible to submit their abstract under special YRF (young researcher’s forum), poster and e-poster presentation category. NOTE: YRF category includes short oral presentation especially for Ph. D. students

• Extended abstract: Submissions should utilize the Abstract Template. Papers submitted in this category may represent original empirical research, theoretical development, reviews, or critiques.

VISA-TripAdvisor

Planning a Trip to Vancouver, Canada!!! Attending Meeting!!!

An issue with VISA!!

Pediatric Oncology 2023 Committee will be happy to help you in all regards to plan your trip to Vancouver, Canada. Avail the official invitation letter from us to attend this event ahead with a closer step for approval of your VISA.

Find out what you need to do to visit Canada as a tourist or business person, how to extend your stay in Canada and what documents you need to carry with you to transit through Canada.

Application submission:

Canada does not have a visa office in every country so it is important that Delegates/Attendees visit the website of the visa office responsible for processing their visa applications.  Information is available on the website on how to submit a visa application and the documentation required. 

Delegates/Attendees are encouraged to submit their visa applications well in advance of the date of the event at a Visa Application Centre or on-line E-applications (e-Apps).

E-Apps

This system allows clients to submit applications online.

Delegates/Attendees that need a visa but require their passport for other travel purposes are strongly encouraged to submit their visa applications online (e-Apps).  Delegates/Attendees that choose to apply online will not have to submit their passport until a decision has been taken on their applications.  If required, the visa office will send the applicant instructions on how and where to send their passports to finalize the visa process.  

Visa Application Centers (VACs):

VACs are commercial service providers authorized by Canada to provide specific services to applicants. 

VACs provide a number of services including help applicants fill out forms, answer questions and ensure that applications are complete, thereby reducing unnecessary delays or refusals due to incomplete applications.

Applicants that are required to provide biometrics information as part of the visa application process can do so at a VAC.  Additional information on the biometrics requirements is available at the IRCC website.

VACs send applications to Visa Offices and transmit decisions to applicants in a secure and confidential manner. VACs do not process visa applications and play no role in the decision-making process.

Visa Applications Processing Time:

Processing time for visa applications vary depending on the office and the time of the year.  Participants should be encouraged to apply early for their visas, and to submit complete applications including all supporting documents.  

Please visit the IRCC website for information on the time it takes to process visa applications at the various visa offices. 

NEW - Electronic Travel Authorization (eTA)

As of March 15, 2016, visa-exempt foreign nationals are expected to have an Electronic Travel Authorization (eTA) to fly to or transit through Canada. Exceptions include U.S. citizens and travelers with a valid Canadian visa. Canadian c-itizens, including dual citizens, and  Canadian permanent residents are not eligible to apply for an eTA.

However, from March 15, 2016, until fall 2016, travelers who do not have an eTA can board their flight, as long as they have appropriate travel documents, such as a valid passport. During this time, border services officers can let travelers arriving without an eTA into the country, as long as they meet the other requirements to enter Canada. We invite you to consult the IRCC website regularly for information updates on eTA.

Best Tourist Destination: Vancouver

• Stanley Park
• Granville Island
• Grouse Mountain
• Museum of Anthropology
• Kitsilano Beach
• Gastown
• Canada Place
• Chinatown
• English Bay
• Capilano Suspension Bridge
• Robson Street
• Museum of Vancouver
• Queen Elizabeth Park
• Science World
• Richmond & Many more…